Physician profile
Peter P Hinh
NPI 1033404629
$3,027.77
in general payments reported to CMS, 2019-2025
32 companies · $197 in 2025
The $197 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $664 · 2020: $107 · 2021: $431 · 2022: $562 · 2023: $621 · 2024: $444 · 2025: $197.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,263.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,262.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $605.07 | 2019-2024 | Xtandi |
| Procept Biorobotics Corporation | $303.09 | 2023-2025 | Aquabeam Robotic System, Aquabeam System |
| Coloplast Corp | $249.87 | 2019-2023 | Saffron |
| Antares Pharma, INC. | $247.23 | 2021-2025 | Xyosted, Nocdurna, Tlando |
| Axonics, INC. | $205.15 | 2023-2024 | Axonics |
| Pfizer INC. | $195.66 | 2019-2023 | |
| Endo Pharmaceuticals INC. | $186.34 | 2019-2023 | Xiaflex, Aveed |
| Boston Scientific Corporation | $167.79 | 2020-2025 | Bodyguardian, Rezum Generator |
| 180 Medical, INC. | $137.37 | 2019-2024 | |
| Medtronic, INC. | $60.88 | 2021-2022 | |
| Halozyme INC | $59.13 | 2023 | |
| Laborie Medical Technologies Corp. | $48.79 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $47.27 | 2023-2025 | Gemtesa |
| Convatec INC. | $43.33 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $41.96 | 2022-2023 | Lifevest |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $41.75 | 2019 | |
| Merck Sharp & Dohme LLC | $40.37 | 2023-2024 | Bridion, Keytruda, Lynparza |
| C. R. Bard, INC. & Subsidiaries | $35.79 | 2021 | |
| Smith+Nephew, INC. | $33.91 | 2023 | Stravix Pl |
| Urogen Pharma, INC. | $31.71 | 2022 | |
| Janssen Biotech, INC. | $24.86 | 2024 | Erleada |
| Endo USA, INC. | $24.69 | 2024 | Xiaflex, Aveed |
| Irhythm Technologies, INC. | $23.78 | 2024 | Zio Monitor, Zio Xt Patch |
| Teleflex LLC | $23.74 | 2022 | |
| Olympus America INC. | $23.57 | 2021 | |
| Urovant Sciences INC | $21.69 | 2022 | |
| Progenics Pharmaceuticals, INC. | $19.59 | 2022 | |
| Verity Pharmaceuticals INC. | $19.13 | 2025 | Trelstar |
| Medtronic USA, INC. | $17.95 | 2019 | |
| Neotract INC. | $17.51 | 2020 | |
| Allergan, INC. | $15.07 | 2019 | |
| Civco Medical Instruments | $13.73 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Hinh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.